Vitamin D and lymphoid cancers: A review
Abstract
Author(s): Akaba kingsley, Akaba kingsley*, Marcus Inyama, Edakabasi Akaba, Theophilus Ugbem and Ofem Enang
Background: Lymphoid Cancers (LC), is a heterogeneous monoclonal group of disorder with accumulation of abnormal of lymphocytes in the blood, bone marrow and reticule-endothelia tissue. LC is the commonest hematological cancers and constitutes the 5th most common cancer. Vitamin D, is crucial with respect to outcome and prognosis. However, there is death and inconsistency of data on Vitamin D in LC.
Aim: The aim of this review is to determine the role and level of Vitamin D in Lymphoid cancers.
Method: A vigorous search was run via various academic search engine, such as Ebsco, Hinari, google scholar, Scopus etc.
Conclusion: The role of vitamin D in lymphoid malignancies has been underscore; this review will help to awaken health practioner with bias for lymphoid cancers on the importance of vitamin D with the insight into further research for development of therapeutic intervention
Share this article
Editors List
-
Ahmed Hussien Alshewered
University of Basrah College of Medicine, Iraq
-
Sudhakar Tummala
Department of Electronics and Communication Engineering SRM University – AP, Andhra Pradesh
-
Alphonse Laya
Supervisor of Biochemistry Lab and PhD. students of Faculty of Science, Department of Chemistry and Department of Chemis
-
Fava Maria Giovanna
- Manuprasad Avaronnan
Onkologia i Radioterapia peer review process verified at publons
Indexed In
- Directory of Open Access Journals
- Scimago
- SCOPUS
- EBSCO A-Z
- MIAR
- Euro Pub
- Google Scholar
- Medical Project Poland
- PUBMED
- Cancer Index
- Gdansk University of Technology, Ministry Points 20